share_log

華領醫藥-B:股份發行人的證券變動月報表

HUA MEDICINE-B: Monthly Return of Equity Issuer on Movements in Securities

HKEX ·  May 7 04:52

Summary by Futu AI

華領醫藥-B(02552.HK)於2024年5月7日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年4月30日的公司股份變動情況。報告顯示,公司的法定/註冊股本及已發行股份在本月內均無變動,維持在2,000,000,000股普通股,每股面值0.001美元,法定/註冊股本總額為2,000,000美元。此外,根據公司股份期權計劃,本月底結存的股份期權數目為52,897,591,而本月內並無新股份發行。公司秘書袁頴欣確認,所有證券發行均已獲董事會授權,並符合香港聯合交易所有限公司證券上市規則的相關要求。
華領醫藥-B(02552.HK)於2024年5月7日向香港交易及結算所有限公司提交了最新的證券變動月報表,報告截至2024年4月30日的公司股份變動情況。報告顯示,公司的法定/註冊股本及已發行股份在本月內均無變動,維持在2,000,000,000股普通股,每股面值0.001美元,法定/註冊股本總額為2,000,000美元。此外,根據公司股份期權計劃,本月底結存的股份期權數目為52,897,591,而本月內並無新股份發行。公司秘書袁頴欣確認,所有證券發行均已獲董事會授權,並符合香港聯合交易所有限公司證券上市規則的相關要求。
Hua Ling Pharmaceutical-B (02552.HK) filed its latest Securities Changes Month Report with Hong Kong Trading and Settlement Limited on May 7, 2024, reporting the change in company shares for the year ended April 30, 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH AT 2,000,000,000 SHARES OF ORDINARY SHARES WITH A FACE VALUE OF $0.001 PER SHARE AND A TOTAL STATUTORY/REGISTERED SHARE CAPITAL OF $2,000,000. In addition, under the Company's stock option plan, the number of stock options outstanding at the end of the month was 52,897,591, and no new shares were issued during the month. COMPANY SECRETARY YUAN WING-XIN CONFIRMED THAT ALL SECURITIES ISSUANCE HAD BEEN AUTHORISED BY THE BOARD OF DIRECTORS AND COMPLIED WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.
Hua Ling Pharmaceutical-B (02552.HK) filed its latest Securities Changes Month Report with Hong Kong Trading and Settlement Limited on May 7, 2024, reporting the change in company shares for the year ended April 30, 2024. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES REMAINED UNCHANGED DURING THE MONTH AT 2,000,000,000 SHARES OF ORDINARY SHARES WITH A FACE VALUE OF $0.001 PER SHARE AND A TOTAL STATUTORY/REGISTERED SHARE CAPITAL OF $2,000,000. In addition, under the Company's stock option plan, the number of stock options outstanding at the end of the month was 52,897,591, and no new shares were issued during the month. COMPANY SECRETARY YUAN WING-XIN CONFIRMED THAT ALL SECURITIES ISSUANCE HAD BEEN AUTHORISED BY THE BOARD OF DIRECTORS AND COMPLIED WITH THE RELEVANT REQUIREMENTS OF THE SECURITIES LISTING RULES OF THE HONG KONG STOCK EXCHANGE LIMITED.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.